Skip to main content

Animations

MJFF Publications

3261 - 3270 of 6560 Results
Title
Year
  • Year
  • 2017
  • 2026
  • 2025
  • 2016
  • 2013
  • 2016
  • 2013
  • 2016
  • 2016
  • 2018
  • Summary Details
    OPEN
    Title: Orthostatic hypotension in Parkinson disease: Impact on health care utilization
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.11.344
    Citation Count: 48
  • Summary Details
    OPEN
    Title: Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations
    Journal Name: Acta Pharmaceutica Sinica B
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.apsb.2026.03.031
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Prospective longitudinal cohort of Argentinean patients with progressive supranuclear palsy and corticobasal syndrome: A platform for epidemiological and translational research
    Journal Name: Clinical Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100339
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Nilotinib – Differentiating the Hope from the Hype
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-160904
    Citation Count: 32
  • Summary Details
    OPEN
    Title: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25600
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Enabling breakthroughs in Parkinson’s disease with wearable technologies and big data analytics
    Journal Name: mHealth
    Publisher: AME Publishing Company
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.21037/mhealth.2016.04.02
    Citation Count: 35
  • Summary Details
    OPEN
    Title: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein‐specific antibodies
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.12508
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/jnen/nlw047
    Citation Count: 146
  • Summary Details
    OPEN
    Title: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27385
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.